These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 22441248

  • 1. When should HAART be initiated in pregnancy to achieve an undetectable HIV viral load by delivery?
    Read PJ, Mandalia S, Khan P, Harrisson U, Naftalin C, Gilleece Y, Anderson J, Hawkins DA, Taylor GP, de Ruiter A, London HIV Perinatal Research Group.
    AIDS; 2012 Jun 01; 26(9):1095-103. PubMed ID: 22441248
    [Abstract] [Full Text] [Related]

  • 2. Does pregnancy affect the early response to cART?
    Rachas A, Warszawski J, Le Chenadec J, Legeai C, Teglas JP, Goujard C, Rouzioux C, Mandelbrot L, Tubiana R, Meyer L.
    AIDS; 2013 Jan 28; 27(3):357-67. PubMed ID: 23079802
    [Abstract] [Full Text] [Related]

  • 3. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N, Sokoloff A, Kornak J, Leva NV, Mendiola ML, Levison J, Feakins C, Shannon M, Cohan D.
    BJOG; 2013 Nov 28; 120(12):1534-47. PubMed ID: 23924192
    [Abstract] [Full Text] [Related]

  • 4. Factors associated with viral load suppression in HIV-infected pregnant women in Rio de Janeiro, Brazil.
    Joao EC, Gouvêa MI, Menezes JA, Sidi LC, Cruz ML, Berardo PT, Ceci L, Cardoso CA, Teixeira Mde L, Calvet GA, Matos HJ.
    Int J STD AIDS; 2012 Jan 28; 23(1):44-7. PubMed ID: 22362687
    [Abstract] [Full Text] [Related]

  • 5. Influence of short-course antenatal antiretroviral therapy on viral load and mother-to-child transmission in subsequent pregnancies among HIV-infected women.
    French CE, Tookey PA, Cortina-Borja M, de Ruiter A, Townsend CL, Thorne C.
    Antivir Ther; 2013 Jan 28; 18(2):183-92. PubMed ID: 23475123
    [Abstract] [Full Text] [Related]

  • 6. [Mode of delivery of HIV-infected women: a retrospective study of 358 pregnancies followed in the same hospital between 2000 and 2004].
    Rodrigues A, Faucher P, Batallan A, Allal L, Legac S, Matheron S, Madelenat P.
    Gynecol Obstet Fertil; 2006 Apr 28; 34(4):304-11. PubMed ID: 16574463
    [Abstract] [Full Text] [Related]

  • 7. Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites.
    Read JS, Cahn P, Losso M, Pinto J, Joao E, Duarte G, Cardoso E, Freimanis-Hance L, Stoszek SK, NISDI Perinatal Study Group.
    Obstet Gynecol; 2007 Jun 28; 109(6):1358-67. PubMed ID: 17540808
    [Abstract] [Full Text] [Related]

  • 8. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
    Kowalska A, Niemiec T, El Midaoui A, Burkacka E.
    Med Wieku Rozwoj; 2003 Jun 28; 7(4 Pt 1):459-68. PubMed ID: 15010556
    [Abstract] [Full Text] [Related]

  • 9. Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.
    Senise JF, Castelo A, Martínez M.
    AIDS Rev; 2011 Jun 28; 13(4):198-213. PubMed ID: 21975356
    [Abstract] [Full Text] [Related]

  • 10. Antiretroviral treatment during pregnancy.
    Keiser O, Gayet-Ageron A, Rudin C, Brinkhof MW, Gremlich E, Wunder D, Drack G, Hirschel B, de Tejada BM, Swiss HIV Cohort Study (SHCS), Swiss Mother & Child HIV Cohort Study (MoCHiV).
    AIDS; 2008 Nov 12; 22(17):2323-30. PubMed ID: 18981771
    [Abstract] [Full Text] [Related]

  • 11. Initiation of highly active antiretroviral therapy among pregnant women in Cape Town, South Africa.
    Stinson K, Boulle A, Coetzee D, Abrams EJ, Myer L.
    Trop Med Int Health; 2010 Jul 12; 15(7):825-32. PubMed ID: 20497405
    [Abstract] [Full Text] [Related]

  • 12. Increased rate of prematurity associated with antenatal antiretroviral therapy in a German/Austrian cohort of HIV-1-infected women.
    Grosch-Woerner I, Puch K, Maier RF, Niehues T, Notheis G, Patel D, Casteleyn S, Feiterna-Sperling C, Groeger S, Zaknun D, Multicenter Interdisciplinary Study Group Germany/Austria.
    HIV Med; 2008 Jan 12; 9(1):6-13. PubMed ID: 18199167
    [Abstract] [Full Text] [Related]

  • 13. Factors associated with mother-to-child transmission of HIV-1 despite a maternal viral load <500 copies/ml at delivery: a case-control study nested in the French perinatal cohort (EPF-ANRS CO1).
    Tubiana R, Le Chenadec J, Rouzioux C, Mandelbrot L, Hamrene K, Dollfus C, Faye A, Delaugerre C, Blanche S, Warszawski J.
    Clin Infect Dis; 2010 Feb 15; 50(4):585-96. PubMed ID: 20070234
    [Abstract] [Full Text] [Related]

  • 14. Mode of Delivery among HIV-Infected Pregnant Women in Philadelphia, 2005-2013.
    Thompson DR, Momplaisir FM, Adams JW, Yehia BR, Anderson EA, Alleyne G, Brady KA.
    PLoS One; 2015 Feb 15; 10(12):e0144592. PubMed ID: 26657902
    [Abstract] [Full Text] [Related]

  • 15. Prevention of human immunodeficiency virus mother-to-child transmission in Israel.
    Agmon-Levin N, Elbirt D, Asher I, Torten D, Cohen Y, Gradestein S, Werner B, Turner D, Chowers M, Gottesman G, Maayan S, Risenberg K, Levi I, Sthoeger Z.
    Int J STD AIDS; 2009 Jul 15; 20(7):473-6. PubMed ID: 19541889
    [Abstract] [Full Text] [Related]

  • 16. Outcome of pregnancy in HIV-positive women planned for vaginal delivery under effective antiretroviral therapy.
    Islam S, Oon V, Thomas P.
    J Obstet Gynaecol; 2010 Jan 15; 30(1):38-40. PubMed ID: 20121502
    [Abstract] [Full Text] [Related]

  • 17. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
    Ekouevi DK, Coffie PA, Becquet R, Tonwe-Gold B, Horo A, Thiebaut R, Leroy V, Blanche S, Dabis F, Abrams EJ.
    AIDS; 2008 Sep 12; 22(14):1815-20. PubMed ID: 18753864
    [Abstract] [Full Text] [Related]

  • 18. Patterns, predictors, and consequences of initial regimen type among HIV-infected women receiving highly active antiretroviral therapy.
    Golub ET, Benning L, Sharma A, Gandhi M, Cohen MH, Young M, Gange SJ.
    Clin Infect Dis; 2008 Jan 15; 46(2):305-12. PubMed ID: 18171267
    [Abstract] [Full Text] [Related]

  • 19. Short-term antiretroviral therapy to prevent mother-to-child transmission is safe and results in a sustained increase in CD4 T-cell counts in HIV-1-infected mothers.
    Palacios R, Senise J, Vaz M, Diaz R, Castelo A.
    HIV Med; 2009 Mar 15; 10(3):157-62. PubMed ID: 19245537
    [Abstract] [Full Text] [Related]

  • 20. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
    Panel de expertos de GESIDA y Plan Nacional sobre el Sida.
    Enferm Infecc Microbiol Clin; 2011 Mar 15; 29(3):209.e1-103. PubMed ID: 21388714
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.